Accuracy of mammography and clinical breast examination in the implementation of breast cancer screening programs in Colombia

Alba, Luz Helena; Díaz, Sandra; Gamboa, Óscar; Poveda, César; Henao, Andrés; Perry, Fernando; Duggan, Catherine; Gil, Fabián; Murillo, Raúl

doi:10.1016/j.ypmed.2018.08.005

Cited by 15 publications

(13 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…10 However, ultrasound is operator dependent and requires equipment and image interpretation. 11 Consequently, clinical breast examination by a healthcare professional is the primary breast cancer detection method, 12,13 and enables prompt evaluation of symptomatic women, can detect breast cancer at an earlier stage, and can reduce breast cancer mortality. 14 However, clinical breast examination requires experienced examiners and quality can be inconsistent, with a wide sensitivity range (22-85%).…”

Section: Introductionmentioning

confidence: 99%

The iBreastExam versus clinical breast examination for breast evaluation in high risk and symptomatic Nigerian women: a prospective study

Mango

Olasehinde

Omisore

et al. 2022

The Lancet Global Health

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

The iBreastExam versus clinical breast examination for breast evaluation in high risk and symptomatic Nigerian women: a prospective study

Mango

Olasehinde

Omisore

et al. 2022

The Lancet Global Health

View full text Add to dashboard Cite

“…Adding ultrasound to CBE and fine needle aspiration (FNA) biopsy may overcome barriers and improve downstaging by reducing visits and providing care closer to where women live 16. In Colombia, women involved in breast cancer early detection underwent up to five visits between the initial screening visit and beginning treatment, if breast cancer were diagnosed 17. Breast cancer survival rates at 5 years may go from 70% in Ecuador as compared to 90% in the USA; 5-year survival for cervical cancer can be of 23 points difference in Asian cancer registries (ie, Korea 78%, Thailand 55%) or 35 points difference in the few African cancer registries (72% in Algeria, 38% in South Africa) 2.…”

Section: Introductionmentioning

confidence: 99%

<p>Prevention of cervical and breast cancer mortality in low- and middle-income countries: a window of opportunity</p>

Sanjosé¹,

Tsu²

2019

IJWH

View full text Add to dashboard Cite

Breast and cervical cancer are the two most common women’s cancers worldwide. Countries have invested for decades in early detection programs for breast and cervical cancer through screening, community education, and opportunistic case detection by health professionals. However, effectiveness in low- and middle-income countries (LMICs) has been limited due to low coverage, insufficient laboratory capacities for diagnosis, health information systems (HIS) that are not designed to track patients or monitor program performance, barriers that inhibit women’s uptake of services, and inadequate treatment options. Even where some screening activities exist, there has not been sufficient attention to ensuring completion of appropriate diagnosis and treatment after women receive a positive screening test result or report symptoms suggesting cervical or breast cancer. Because of this failure to provide adequate follow-up care, these women miss the potential benefit from early detection and have a higher than average risk to develop cancer or progress to more advanced cancer stages that could have been avoided. There are several critical steps in a woman’s journey from good health to elevated cancer risk, then to cancer prevention or diagnosis, and finally to treatment. There is a window of opportunity that extends from the time a positive finding is identified—by a cervical or breast screening test or recognition of a breast abnormality—to the point when cervical precancer treatment is delivered or a treatment plan for diagnosed breast cancer is initiated. Building on existing health systems and adapting measurable, affordable, and culturally acceptable interventions can achieve a lasting impact. If women can successfully navigate this window of opportunity, they can avoid progression to cervical cancer or greatly reduce the need for invasive treatments for breast cancer and improve their chances for survival and improved quality of life. We propose several actions that can lead us on the path towards reduction of this cancer burden.

show abstract

“…In a study by Alba et al, the sensitivity and specificity of mammography were 78.3% (95% CI 77.3-99.3) and 99.4% (95% CI 99.2-99.6), respectively. The authors concluded that several factors could influence the accuracy of mammography, including age, breast density, menopausal status [16]. Besides, significant variation could be due to the interpretation of the mammography by different readers.…”

Section: Discussionmentioning

confidence: 99%

Diagnostic efficacy of physical examination and radiological findings in palpable breast masses

Memişoğlu

Sarı

Tosun

et al. 2022

Turkish Journal of Clinics and Laboratory

View full text Add to dashboard Cite

Amaç: Klinik meme muayenesi (KMM), özellikle düşük ve orta gelirli ülkelerde meme kanserinin erken tanısında önemlidir. Tru-cut biyopsi (TCB), meme kitlesi olan hastalarda patolojik tanı için en sık kullanılan yöntemdir. Bu çalışmada meme kitlesi ile başvuran hastalarda KMM'ye dayalı TCB kararının avantajlarını ve tanısal doğruluğunu değerlendirmeyi amaçladık. Gereç ve Yöntemler: Bu prospektif kohort çalışmada, meme polikliniğimize Eylül 2020 ile Mart 2021 tarihleri arasında başvuran hastaların verileri değerlendirildi. Başvuru şikayetleri, aile öyküsü, hormon replasman tedavisi, kitle boyutu, kontur, mobilite, radyolojik bulgular, BI-RADS sınıflaması ve TCB'nin patolojik tanısı kaydedildi. Çalışmaya meme polikliniğimizde TCB uygulanan toplam 200 hasta dahil edildi. Bulgular: Malign grupta düzensiz ve fikse kitle varlığı Benign gruba kıyasla daha fazla gözlendi (sırasıyla %67.1'e %43.9, P: 0.001; %75.9'a %39, P< 0.001). Regresyon analizinde yaş, meme malignitesi ile anlamlı olarak ilişkiliydi (OR: 1.12, CI %95: 1.06- 1.18). KMM, benign patoloji için %85,5, malignite için %88,5 ve granülomatöz meme kitlesi için %90,2 tutarlılık gösterdi. Sonuç: Fizik muayenede düzensiz sınırlı, fikse meme kitlesi saptanan ileri yaş ve postmenopozal hastalar meme kanseri görülmesi açısından yüksek riskli kabul edilmelidir. TCB, düşük-orta gelirli ülkelerde deneyimli cerrahlar tarafından uygulanmalı ve radyolojinin neden olduğu zaman kaybı ve maliyet azaltılarak kısa sürede tanıya ulaşılmalıdır.

show abstract

Accuracy of mammography and clinical breast examination in the implementation of breast cancer screening programs in Colombia

Cited by 15 publications

References 23 publications

The iBreastExam versus clinical breast examination for breast evaluation in high risk and symptomatic Nigerian women: a prospective study

The iBreastExam versus clinical breast examination for breast evaluation in high risk and symptomatic Nigerian women: a prospective study

<p>Prevention of cervical and breast cancer mortality in low- and middle-income countries: a window of opportunity</p>

Diagnostic efficacy of physical examination and radiological findings in palpable breast masses

Contact Info

Product

Resources

About